Cargando…
Hilar cholangiocarcinoma: Cross sectional evaluation of disease spectrum
Although hilar cholangiocarcinoma is relatively rare, it can be diagnosed on imaging by identifying its typical pattern. In most cases, the tumor appears to be centered on the right or left hepatic duct with involvement of the ipsilateral portal vein, atrophy of hepatic lobe on that side, and invasi...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4419429/ https://www.ncbi.nlm.nih.gov/pubmed/25969643 http://dx.doi.org/10.4103/0971-3026.155871 |
_version_ | 1782369571174350848 |
---|---|
author | Mahajan, Mangal S Moorthy, Srikanth Karumathil, Sreekumar P Rajeshkannan, R Pothera, Ramchandran |
author_facet | Mahajan, Mangal S Moorthy, Srikanth Karumathil, Sreekumar P Rajeshkannan, R Pothera, Ramchandran |
author_sort | Mahajan, Mangal S |
collection | PubMed |
description | Although hilar cholangiocarcinoma is relatively rare, it can be diagnosed on imaging by identifying its typical pattern. In most cases, the tumor appears to be centered on the right or left hepatic duct with involvement of the ipsilateral portal vein, atrophy of hepatic lobe on that side, and invasion of adjacent liver parenchyma. Multi-detector computed tomography (MDCT) and magnetic resonance cholangiopancreatography (MRCP) are commonly used imaging modalities to assess the longitudinal and horizontal spread of tumor. |
format | Online Article Text |
id | pubmed-4419429 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-44194292015-05-12 Hilar cholangiocarcinoma: Cross sectional evaluation of disease spectrum Mahajan, Mangal S Moorthy, Srikanth Karumathil, Sreekumar P Rajeshkannan, R Pothera, Ramchandran Indian J Radiol Imaging Abdominal Radiology Although hilar cholangiocarcinoma is relatively rare, it can be diagnosed on imaging by identifying its typical pattern. In most cases, the tumor appears to be centered on the right or left hepatic duct with involvement of the ipsilateral portal vein, atrophy of hepatic lobe on that side, and invasion of adjacent liver parenchyma. Multi-detector computed tomography (MDCT) and magnetic resonance cholangiopancreatography (MRCP) are commonly used imaging modalities to assess the longitudinal and horizontal spread of tumor. Medknow Publications & Media Pvt Ltd 2015 /pmc/articles/PMC4419429/ /pubmed/25969643 http://dx.doi.org/10.4103/0971-3026.155871 Text en Copyright: © Indian Journal of Radiology and Imaging http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Abdominal Radiology Mahajan, Mangal S Moorthy, Srikanth Karumathil, Sreekumar P Rajeshkannan, R Pothera, Ramchandran Hilar cholangiocarcinoma: Cross sectional evaluation of disease spectrum |
title | Hilar cholangiocarcinoma: Cross sectional evaluation of disease spectrum |
title_full | Hilar cholangiocarcinoma: Cross sectional evaluation of disease spectrum |
title_fullStr | Hilar cholangiocarcinoma: Cross sectional evaluation of disease spectrum |
title_full_unstemmed | Hilar cholangiocarcinoma: Cross sectional evaluation of disease spectrum |
title_short | Hilar cholangiocarcinoma: Cross sectional evaluation of disease spectrum |
title_sort | hilar cholangiocarcinoma: cross sectional evaluation of disease spectrum |
topic | Abdominal Radiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4419429/ https://www.ncbi.nlm.nih.gov/pubmed/25969643 http://dx.doi.org/10.4103/0971-3026.155871 |
work_keys_str_mv | AT mahajanmangals hilarcholangiocarcinomacrosssectionalevaluationofdiseasespectrum AT moorthysrikanth hilarcholangiocarcinomacrosssectionalevaluationofdiseasespectrum AT karumathilsreekumarp hilarcholangiocarcinomacrosssectionalevaluationofdiseasespectrum AT rajeshkannanr hilarcholangiocarcinomacrosssectionalevaluationofdiseasespectrum AT potheraramchandran hilarcholangiocarcinomacrosssectionalevaluationofdiseasespectrum |